Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
realSKIN
- Development stage
- Phase 3
- Lead developer
- Alexis Bio
- Modality
- Tissue Cells → Other Cell Types → Cell Therapies
- Administration
- Topical
01
Overview
realSKIN is a live cell xenotransplant product developed as an off-the-shelf regenerative medicine therapy for severe and extensive deep-partial and full-thickness thermal burn wounds. It is designed to provide complete and durable wound closure from a single application by promoting autologous skin regeneration, serving as an alternative to traditional autografting in patients requiring hospitalization, surgical excision, and skin grafting. realSKIN is the first live cell xenotransplant product to receive Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA). The therapy is currently being evaluated in Phase 3 clinical trials for its safety, tolerability, and efficacy in burn wound management[6].
- Brand names
- realSKIN
- Other names
- realSKIN
Beyond the preview
Go deeper on realSKIN.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on realSKIN.